O’Melveny’s Congressional Investigations team is a trusted ally to companies, organizations and individuals responding to Congressional investigative subpoenas, facing ethics inquiries and related criminal investigations, and preparing for testimony at Congressional oversight hearings.
Our clients benefit from a team of talented lawyers with decades of government experience and creative approaches to investigations—lawyers who are equally well equipped to help clients manage their public relations, political strategy, and collateral litigation. We routinely handle complex, high-profile investigations; for example, we recently handled an investigation that included a nationally televised hearing, witness interviews, and document productions to four different, simultaneous investigations by House and Senate committees. And with experience that extends well beyond Congress, we also routinely represent corporations, audit committees, individual officers and directors, and others in internal, SEC, DOJ, and state attorney-general investigations.
Our team is led by K. Lee Blalack, II, a former chief counsel and staff director of the US Senate’s Permanent Subcommittee on Investigations.
- A national nonprofit organization in multiple congressional investigations concerning allegations related to the facilitation of fetal tissue donation. The investigations included a nationally televised hearing, witness interviews, and document productions to four different, simultaneous investigations by House and Senate committees.
- A consumer electronics company in an investigation of its data security policies, particularly regarding the selection and dissemination of customer information.
- A leading technology company in Senate inquiry concerning overseas corporate structuring and tax practices
- An individual in a Congressional investigation related to an FTC enforcement action concerning a data breach incident.
- A senator in connection with a federal grand jury and Senate Ethics Committee investigation.
- A former Senate Majority Leader in connection with investigations surrounding his sale of stock from federally qualified blind trusts.
- A financial services company in connection with a Senate investigation of its offshore banking business.
- A healthcare company in connection with Senate and House investigations of its business practices in the small group and individual health insurance markets.
- A financial institution in connection with a Senate investigation of its subprime mortgage business, and a House investigation of its executive compensation practices.
- A member of the House of Representatives in connection with a Federal Grand Jury investigation and a Congressional Ethics inquiry.
- A former governor and EPA administrator in connection with a House investigation of EPA’s response to the terrorist attacks of September 11, 2001.
- An automotive company in connection with numerous House and Senate investigations of a tire recall.
- A former CEO in connection with numerous House and Senate investigations of a high-profile bankruptcy.
- A pharmaceutical company in connection with a House investigation of the U.S. Food and Drug Administration's denial of the company’s biologics license application for an anti-cancer drug.
- An Ivy League university in connection with a House investigation of a laboratory contract awarded by the National Cancer Institute.
- An oil company in connection with a Senate investigation of its business operations in Equatorial Guinea and Gabon.
- A museum in connection with a Senate investigation of its conduct as a tax-exempt organization.
- The CEO of a consumer products company in connection with a House investigation of the company’s marketing of dietary supplements
- A healthcare company in connection with a Senate investigation of corporate sponsorship of medical research
- The former Chief Counsel to the Speaker of the House in connection with a House Ethics Committee investigation of Representative Mark Foley
- A former Cabinet member in connection with a House Oversight Committee investigation.
- A health care company in connection with Senate and House investigations of its business practices in the small group and individual health insurance markets.
Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.
"Congressional hearings feature prominently among the team’s mandates ... Additional expertise within the firm includes conducting internal investigations."
Legal 500 - US